Skip to content
Environment, Medical Health Aged Care

Manmade pollutants and climate change contribute to millions of deaths from cardiovascular disease each year, warn a coalition of leading scientists

Victor Chang Cardiac Research Institute 3 mins read
Adobe stock image

A new series published in the Journal of the American College of Cardiology highlights how pollution, in all its forms, is a greater health threat than that of war, terrorism, malaria, HIV, tuberculosis, drugs and alcohol combined.

The researchers from the  the Victor Chang Cardiac Research Institute, University of Edinburgh, Icahn School of Medicine at Mount Sinai, Global Observatory on Planetary Health Boston College, Centre Scientifique de Monaco and the  University Medical Centre Mainz focus on global warming, air pollution and exposure to wildfire smoke, and highlight the lesser-known drivers of heart disease including soil, noise and light pollution, and exposure to toxic chemicals.

They say there is an urgent need to improve the monitoring of these pollutants to identify communities most at risk, and better understand how exposure to specific pollutants raises the risk of cardiovascular disease at the individual level.

Professor Jason Kovacic, Director and CEO of the Victor Chang Cardiac Research Institute, says there needs to be far greater recognition of the dangers of pollution and the role they play in causing around nine million deaths each year globally.

Professor Kovacic says: “Every year around 20 million people worldwide die from cardiovascular disease with pollutants playing an ever-increasing role.

“Pollutants have reached every corner of the globe and are affecting every one of us. We are witnessing unprecedented wildfires, soaring temperatures, unacceptable road noise and light pollution in our cities and exposure to untested toxic chemicals in our homes.

“Our bodies are being bombarded with pollutants from every angle and they are taking a toll on our heart health.  The evidence suggests that the number of people dying prematurely because of these very different forms of pollution is far higher than currently recognized.”

Pollutants are known drivers of cardiovascular disease, but they affect the body in different ways. Smoke and other toxins can be directly inhaled deep into the lower respiratory tract and reach the blood and then be transported to other organs and throughout our bodies. They can cause oxidative stress which can damage cells and organs including the heart.

Other pollutants like noise and light pollution can affect sleep patterns, drive inflammation and lead to an increase in blood pressure and weight gain. Extreme heat can also lead to dehydration, decreased blood volume, increased cardiovascular strain, and acute kidney failure.

Professor Kovacic adds: “Whilst many of these biological mechanisms are known, we still have a huge gap in our understanding of the link between pollutants and heart disease.

“There are hundreds of thousands of chemicals that haven’t even been tested for their safety or toxicity, let alone their impact on our health. We also need to discover if there are other risk factors that make people more susceptible – such as pre-existing conditions, lifestyle factors or where they live.”

Professor Kovacic and the other authors say that in the future, people will be routinely tested for exposure to more pollutants – just like children are currently tested for lead exposure in the USA.

The authors note that while the environmental crisis is imminent, and impact on health ever more pressing, the impetus for change appears sporadic.  “Urgent action is required as climate change strides forward and pollution infiltrates the air we breathe, the water we drink, the food we eat, and the places we live in,” they write.

The team of researchers make a series of recommendations including:

  1. Calling for the implementation of heart-healthy changes to city design such as increasing tree cover, safe means of active travel and reduced use of vehicles.
  2. Ending subsidies to the fossil fuel industry to enable more investment in renewables and cleaner energy production.
  3. Public health campaigns about the dangers of air pollution.
  4. Medical education to better reflect the growing dangers of pollutants.

Key statistics

  • Outdoor and indoor air pollution combined, are associated with over seven million premature deaths per year, of which over 50% are attributable to cardiovascular causes, principally ischemic heart disease and stroke.
  • A fifth of all cardiovascular deaths are caused by air pollution.
  • During heat waves, the risk of heat-related cardiovascular mortality may increase by more than 10%.
  • In the USA there has been a 77% increase in exposure to wildfire smoke since 2002.
  • Globally, wildfire smoke has been estimated to be responsible for 339,000 to 675,000 premature deaths per year.
  • Over 300,000 new synthetic chemicals have been manufactured since 1950, and the human safety profile of many of these chemicals is unknown.
  • In Europe it is estimated 113 million people are affected by long-term day-evening-night traffic noise levels of at least 55 dB(A). 



Contact details:

Please contact Julia Timms at or +61 457517355 to arrange interviews with Professor Jason Kovacic. 


More from this category

  • Medical Health Aged Care
  • 24/06/2024
  • 17:07
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the Most Common…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/06/2024
  • 16:20
National Rural Health Alliance

Community-led innovation to revolutionise healthcare access in rural Australia

The National Rural Health Alliance (the Alliance) is delighted that the Minister for Health and Aged Care, the Hon Mark Butler, has today announced…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 24/06/2024
  • 12:25
Jane Morgan Management

Imugene (ASX:IMU) Doses First Patient in Pioneering Phase 1 onCARlytics Trial

Sydney, Australia, 24 June 2024: Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is thrilled to announce the dosing of the first patient in the intravenous (IV) infusion combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial. This groundbreaking trial, named OASIS, is being conducted at City of Hope in California and is designed to transform the treatment landscape for patients with advanced solid tumors. The OASIS trial is a world-first, combining a CD19-expressing oncolytic virus with a CD19-targeting drug. The trial aims to recruit 40-45 patients with advanced solid cancers that have metastasized, with preliminary early combination data…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.